Event-level associations among THC, CBD, social context, and subjective effects during Cannabis use episodes.

IF 4.5 3区 医学 Q1 CLINICAL NEUROLOGY
Journal of Psychopharmacology Pub Date : 2024-11-01 Epub Date: 2024-08-16 DOI:10.1177/02698811241269800
Yi-Chun Chang, Renee E Magnan, Michael J Cleveland, Benjamin O Ladd
{"title":"Event-level associations among THC, CBD, social context, and subjective effects during Cannabis use episodes.","authors":"Yi-Chun Chang, Renee E Magnan, Michael J Cleveland, Benjamin O Ladd","doi":"10.1177/02698811241269800","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Limited research considers the quantity and potency of cannabis products along with social context on the subjective effects of real-world cannabis use.</p><p><strong>Aims: </strong>This study examined the subjective effects of acute use as a function of Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) doses and social context during cannabis use episodes.</p><p><strong>Method: </strong>Ninety-six participants (43.75% male, <i>M</i><sub>age</sub> = 35.73) reporting weekly cannabis use completed a baseline self-report battery assessing cannabis use. Then, THC and CBD potency and quantity of the cannabis product, social context, and subjective experience were assessed through self-initiated surveys after cannabis use episodes during a 14-day ecological momentary assessment (EMA).</p><p><strong>Results: </strong>Greater feeling high and liking were significantly associated with a higher THC dose than one's average (<i>b</i> = 0.03, <i>p</i> < 0.001; <i>b</i> = 0.02, <i>p</i> < 0.001) and social use (<i>b</i> = 0.38, <i>p</i> < 0.001; <i>b</i> = 0.20, <i>p</i> = 0.01). A higher CBD dose than one's average (<i>b</i> = 0.01, <i>p</i> = 0.04) was significantly associated with greater liking. A significant interaction effect of THC dose and social context (<i>b</i> = 0.01, <i>p</i> = 0.02) was observed such that solitary use had a negative association between THC dose and disliking (<i>b</i> = -0.01, <i>p</i> = 0.04), and social use had a null association (<i>b</i> = 0.003, <i>p</i> = 0.25). Individuals with greater cannabis problems reported lower liking (<i>b</i> = -0.18, <i>p</i> = 0.03) and higher disliking (<i>b</i> = 0.08, <i>p</i> = 0.02), but not feeling high, on average, across the EMA protocol.</p><p><strong>Conclusion: </strong>Social context plays an important role in the subjective experience of cannabis use. Interventions targeting cannabis problems could highlight the evidence that individuals with greater cannabis problems might experience less liking but more disliking in general across use episodes to effectively challenge expectancies/motives of use.</p>","PeriodicalId":16892,"journal":{"name":"Journal of Psychopharmacology","volume":" ","pages":"961-971"},"PeriodicalIF":4.5000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Psychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/02698811241269800","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/16 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Limited research considers the quantity and potency of cannabis products along with social context on the subjective effects of real-world cannabis use.

Aims: This study examined the subjective effects of acute use as a function of Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) doses and social context during cannabis use episodes.

Method: Ninety-six participants (43.75% male, Mage = 35.73) reporting weekly cannabis use completed a baseline self-report battery assessing cannabis use. Then, THC and CBD potency and quantity of the cannabis product, social context, and subjective experience were assessed through self-initiated surveys after cannabis use episodes during a 14-day ecological momentary assessment (EMA).

Results: Greater feeling high and liking were significantly associated with a higher THC dose than one's average (b = 0.03, p < 0.001; b = 0.02, p < 0.001) and social use (b = 0.38, p < 0.001; b = 0.20, p = 0.01). A higher CBD dose than one's average (b = 0.01, p = 0.04) was significantly associated with greater liking. A significant interaction effect of THC dose and social context (b = 0.01, p = 0.02) was observed such that solitary use had a negative association between THC dose and disliking (b = -0.01, p = 0.04), and social use had a null association (b = 0.003, p = 0.25). Individuals with greater cannabis problems reported lower liking (b = -0.18, p = 0.03) and higher disliking (b = 0.08, p = 0.02), but not feeling high, on average, across the EMA protocol.

Conclusion: Social context plays an important role in the subjective experience of cannabis use. Interventions targeting cannabis problems could highlight the evidence that individuals with greater cannabis problems might experience less liking but more disliking in general across use episodes to effectively challenge expectancies/motives of use.

在吸食大麻的过程中,四氢大麻酚、CBD、社会环境和主观效果之间的事件级关联。
背景:目的:本研究调查了急性使用大麻的主观效果与Δ9-四氢大麻酚(THC)和大麻二酚(CBD)剂量以及使用大麻期间的社会环境的关系:96名报告每周使用大麻的参与者(43.75%为男性,Mage = 35.73)完成了评估大麻使用情况的基线自我报告。然后,在为期 14 天的生态瞬间评估(EMA)中,在使用大麻后通过自发调查对大麻产品中四氢大麻酚和大麻二酚的效力和数量、社会环境和主观体验进行评估:较高的四氢大麻酚剂量(b = 0.03,p b = 0.02,p b = 0.38,p b = 0.20,p = 0.01)与较高的四氢大麻酚剂量(b = 0.03,p b = 0.02,p b = 0.38,p b = 0.20,p = 0.01)有显著相关性。CBD 剂量高于个人平均值(b = 0.01,p = 0.04)与更大的喜好度明显相关。四氢大麻酚剂量和社会环境(b = 0.01,p = 0.02)之间存在明显的交互效应,因此单独吸食与四氢大麻酚剂量和不喜欢之间存在负相关(b = -0.01,p = 0.04),而社交吸食与不喜欢之间存在负相关(b = 0.003,p = 0.25)。在整个 EMA 方案中,大麻问题较多的个体报告的喜欢程度较低(b = -0.18,p = 0.03),不喜欢程度较高(b = 0.08,p = 0.02),但平均感觉不高:结论:社会环境在大麻使用的主观体验中起着重要作用。针对大麻问题的干预措施可以强调这样的证据,即大麻问题较严重的人在整个使用过程中可能会经历较少的喜欢但更多的不喜欢,从而有效地挑战使用大麻的预期/动机。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Psychopharmacology
Journal of Psychopharmacology 医学-精神病学
CiteScore
8.60
自引率
4.90%
发文量
126
审稿时长
3-8 weeks
期刊介绍: The Journal of Psychopharmacology is a fully peer-reviewed, international journal that publishes original research and review articles on preclinical and clinical aspects of psychopharmacology. The journal provides an essential forum for researchers and practicing clinicians on the effects of drugs on animal and human behavior, and the mechanisms underlying these effects. The Journal of Psychopharmacology is truly international in scope and readership.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信